Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA066626-02
Application #
2110050
Study Section
Special Emphasis Panel (ZRG5-EI (03))
Project Start
1995-04-01
Project End
1999-01-31
Budget Start
1996-02-01
Budget End
1997-01-31
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost
Name
Boston Medical Center
Department
Type
DUNS #
005492160
City
Boston
State
MA
Country
United States
Zip Code
02118
Chaudhuri, A; Orme, S; Vo, T et al. (1999) Phosphorylation of TRAF2 inhibits binding to the CD40 cytoplasmic domain. Biochem Biophys Res Commun 256:620-5
Francis, D A; Sen, R; Rice, N et al. (1998) Receptor-specific induction of NF-kappaB components in primary B cells. Int Immunol 10:285-93
Francis, D A; Sen, R; Rothstein, T L (1997) Receptor-specific regulation of NF-kappa B, c-Myc and Fas-mediated apoptosis in primary B cells. Curr Top Microbiol Immunol 224:83-90
Wang, W; Tam, W F; Hughes, C C et al. (1997) c-Rel is a target of pentoxifylline-mediated inhibition of T lymphocyte activation. Immunity 6:165-74
Schauer, S L; Wang, Z; Sonenshein, G E et al. (1996) Maintenance of nuclear factor-kappa B/Rel and c-myc expression during CD40 ligand rescue of WEHI 231 early B cells from receptor-mediated apoptosis through modulation of I kappa B proteins. J Immunol 157:81-6
Wu, M; Lee, H; Bellas, R E et al. (1996) Inhibition of NF-kappaB/Rel induces apoptosis of murine B cells. EMBO J 15:4682-90
Rothstein, T L (1996) Signals and susceptibility to programmed death in b cells. Curr Opin Immunol 8:362-71